- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ 42.911 ↓ -0.1%
[as on 26 December, 2025]
NAV chart with SMA (Simple moving average) overlay
SMA (Simple Moving Average)
Returns
| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|
| Mirae Asset Healthcare Fund Direct Growth | -2.29% | -0.1% | -0.08% | -0.91% | 1.85% | 0.48% | 23.39% | 16.94% | 22.83% | - |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|
| 99.31% |
0.01% (Arbitrage: 0.00%) |
0.00% |
0.00% |
0.68% |
Equity
| Name | Symbol / ISIN | Sector | Weight % | Quantity | Qty change % |
|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 12.01% | 2004418 | - |
| Divi's Laboratories Ltd. | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 8.88% | 371682 | -1.33% |
| Glenmark Pharmaceuticals Ltd. | GLENMARK (INE935A01035) | Pharmaceuticals & Biotechnology | 6.41% | 956043 | -3.04% |
| Apollo Hospitals Enterprise Ltd. | APOLLOHOSP (INE437A01024) | Healthcare Services | 6.21% | 228046 | -1.72% |
| Cipla Ltd. | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 5.42% | 1018081 | -8.12% |
| Lupin Ltd. | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 5.07% | 729170 | - |
| Fortis Healthcare Ltd. | FORTIS (INE061F01013) | Healthcare Services | 4.33% | 1193084 | - |
| Aurobindo Pharma Ltd. | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 4.09% | 1012443 | -8.17% |
| Dr. Reddy's Laboratories Ltd. | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 4.02% | 946480 | - |
| Krishna Institute of Medical Sciences Ltd. | KIMS (INE967H01025) | Healthcare Services | 3.77% | 1475624 | - |
| IPCA Laboratories Ltd. | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 3.56% | 790212 | +9.72% |
| Aster DM Healthcare Ltd. | ASTERDM (INE914M01019) | Healthcare Services | 3.48% | 1448593 | -3.34% |
| Eris Lifesciences Ltd. | ERIS (INE406M01024) | Pharmaceuticals & Biotechnology | 3.20% | 567024 | +8.17% |
| Alkem Laboratories Ltd. | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 3.19% | 163396 | +14.75% |
| Laurus Labs Ltd. | LAURUSLABS (INE947Q01028) | Pharmaceuticals & Biotechnology | 2.81% | 830748 | +10.66% |
| Cohance Lifesciences Ltd. | COHANCE (INE03QK01018) | Pharmaceuticals & Biotechnology | 2.77% | 1037917 | - |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 2.72% | 215716 | - |
| Onesource Specialty Pharma Ltd. | ONESOURCE (INE013P01021) | Pharmaceuticals & Biotechnology | 2.70% | 411531 | - |
| JB Chemicals & Pharmaceuticals Ltd. | JBCHEPHARM (INE572A01036) | Pharmaceuticals & Biotechnology | 2.68% | 448848 | - |
| Sai Life Sciences Ltd. | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 2.56% | 786462 | - |
| Gland Pharma Ltd. | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 1.61% | 235103 | - |
| Mankind Pharma Ltd. | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 1.55% | 183441 | - |
| Anthem Biosciences Ltd. | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 1.32% | 526318 | - |
| Wockhardt Ltd. | WOCKPHARMA (INE049B01025) | Pharmaceuticals & Biotechnology | 1.28% | 281374 | -17.58% |
| Rubicon Research Ltd. | RUBICON (INE506V01022) | Pharmaceuticals & Biotechnology | 0.82% | 372780 | - |
| Deepak Nitrite Ltd. | DEEPAKNTR (INE288B01029) | Chemicals & Petrochemicals | 0.76% | 124170 | - |
| Sagility Ltd. | SAGILITY (INE0W2G01015) | IT - Services | 0.59% | 3159520 | -39.93% |
| Neogen Chemicals Ltd. | NEOGEN (INE136S01016) | Chemicals & Petrochemicals | 0.53% | 102961 | - |
| Syngene International Ltd. | SYNGENE (INE398R01022) | Healthcare Services | 0.52% | 227181 | - |
| Laxmi Dental Ltd. | LAXMIDENTL (INE0WO601020) | Healthcare Equipment & Supplies | 0.45% | 407121 | - |
| Biocon Ltd. | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 0.01% | 5001 | -99.33% |
Debt
| Name | Rating | Weight % |
|---|
| Mirae Asset Liquid Fund-Direct Plan-Growth | | 0.01% |
Portfolio data is as on date 31 October, 2025
NAV (Net asset value) history
Mirae Asset Healthcare Fund Direct Growth - 30 days NAV history
| Date | NAV |
|---|
| 26 December, 2025 | 42.911 |
| 24 December, 2025 | 42.953 |
| 23 December, 2025 | 43.127 |
| 22 December, 2025 | 43.242 |
| 19 December, 2025 | 42.947 |
| 18 December, 2025 | 42.394 |
| 17 December, 2025 | 42.494 |
| 16 December, 2025 | 42.621 |
| 15 December, 2025 | 42.888 |
| 12 December, 2025 | 42.944 |
| 11 December, 2025 | 42.831 |
| 10 December, 2025 | 42.553 |
| 9 December, 2025 | 42.623 |
| 8 December, 2025 | 42.506 |
| 5 December, 2025 | 43.241 |
| 4 December, 2025 | 43.308 |
| 3 December, 2025 | 43.144 |
| 2 December, 2025 | 43.206 |
| 1 December, 2025 | 43.171 |
| 28 November, 2025 | 43.399 |
| 27 November, 2025 | 43.229 |
| 26 November, 2025 | 43.304 |
| 25 November, 2025 | 42.867 |
| 24 November, 2025 | 42.782 |
| 21 November, 2025 | 42.897 |
| 20 November, 2025 | 43.215 |
| 19 November, 2025 | 43.135 |
| 18 November, 2025 | 43.211 |
| 17 November, 2025 | 43.626 |
| 14 November, 2025 | 43.495 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of Mirae Asset Healthcare Fund Direct Growth?
The latest NAV of Mirae Asset Healthcare Fund Direct Growth is 42.911 as on 26 December, 2025.
What are YTD (year to date) returns of Mirae Asset Healthcare Fund Direct Growth?
The YTD (year to date) returns of Mirae Asset Healthcare Fund Direct Growth are -2.29% as on 26 December, 2025.
What are 1 year returns of Mirae Asset Healthcare Fund Direct Growth?
The 1 year returns of Mirae Asset Healthcare Fund Direct Growth are 0.48% as on 26 December, 2025.
What are 3 year CAGR returns of Mirae Asset Healthcare Fund Direct Growth?
The 3 year annualized returns (CAGR) of Mirae Asset Healthcare Fund Direct Growth are 23.39% as on 26 December, 2025.
What are 5 year CAGR returns of Mirae Asset Healthcare Fund Direct Growth?
The 5 year annualized returns (CAGR) of Mirae Asset Healthcare Fund Direct Growth are 16.94% as on 26 December, 2025.
